Fourteen funding bodies from around the world have committed to improving clinical trial registration and reporting.   The signatories include two major East Asian funders that appear to be publicly committing themselves to trial transparency for the first time: Japan Agency for Medical Research and Development National Institute of Health, Republic of Korea   The trial transparency commitments are included in the wider-ranging WHO-initiated “ Joint statement on strengthening clinical trials...

American academic organisations have significantly increased resources devoted to improving compliance with clinical trials registration and results reporting requirements, a new study  shows.   The authors note that these investments have been paralleled by a strong increase in many universities’ compliance with legal clinical trial transparency requirements. Over the course of six years, the proportion of U.S. organisations with clinical trial registration policies increased to 74%, while...

The PATHWAYS trial of puberty blockers for transgender youth in the UK has received ethics approval and the protocol is now publicly available. The full trial protocol can now be found on the website of King's College London (permalink here ). According to the website of the UK's ethics regulator HRA, the trial received ethics approval in early November . It is unclear whether it has also secured approval from the UK's medicines regulator MHRA. So far, the trial has not been registered on...